This move is archived. Current quotes and coverage live on the stock page.
Get GUD alerts:
Knight Therapeutics Inc. is seeing a drop in its stock price, which is raising concerns among investors.
Knight Therapeutics Inc. (GUD.TO) is having a tough trading day, with its stock price falling by 1.91% to close at CA$9.78. This decline reflects broader market sentiments and investor reactions to recent developments.
Advertisement
Knight Therapeutics Inc.
GUD.TO
GUD.TO
Knight Therapeutics Inc.
WealthAwesomeMarket cap
$957.76M
P/E
65.0x
52W high
$10.17
52W low
$5.66
1W change
-0.61%
Beta
0.05
Analyst Price Targets
Based on analyst covering GUD
Wall Street analysts forecast GUD stock price to rise 14.6% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$11.19
+14.6% Upside
Current Price
C$9.76
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GUD's historical volatility
30-Day Vol
32.3%
Annualized
90-Day Vol
32.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$11.67
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.36 | C$9.27 – C$11.58 |
| 60 trading days | C$10.99 | C$9.39 – C$12.87 |
| 90 trading days | C$11.67 | C$9.62 – C$14.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on Knight Therapeutics' performance and market conditions. The recent drop in stock price might signal underlying issues that need to be addressed.
Knight Therapeutics Inc. stock down 1.91% today
Today's decline shows investor uncertainty, with a market cap of CA$978 million and a P/E ratio that suggests the stock may be overvalued.
Bull case
Despite today’s dip, Knight Therapeutics has a solid market cap of CA$978 million and has reported record revenues in recent quarters. This suggests there’s potential for recovery ahead.
Bear case
The current weakness in Knight Therapeutics' stock price raises concerns about its growth strategy and market position, especially given the high P/E ratio of 166.17, which might deter new investors.
Market Reaction and Stock Performance
Advertisement
Knight Therapeutics Inc. experienced a significant drop in its stock price today, closing down 1.91%. This decline seems linked to investor sentiment, as the company hasn’t released any major news that could have positively influenced the market. Investors are likely reassessing their positions amid uncertainty about the company’s growth trajectory.
Valuation Concerns
With a P/E ratio of 166.17, Knight Therapeutics' stock appears overvalued compared to its earnings. This high valuation could be contributing to the stock's decline, as investors may hesitate to buy into a company that isn't generating enough profits to justify its market price. Therefore, the current pullback might be a signal for investors to rethink their strategies regarding GUD.TO.
Future Outlook
While Knight Therapeutics has shown strong revenue growth in recent quarters, today’s stock performance raises questions about its sustainability. Investors should watch for upcoming earnings reports and market developments, as these will be crucial in determining whether the stock can bounce back from its current downturn. For further insights into Knight Therapeutics' financial performance, visit their stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
